Background: Patients with end-stage kidney disease (ESKD) undergoing hemodialysis, peritoneal dialysis, or kidney transplantation are prone to bleeding complications, partly due to alterations in von Willebrand factor (vWF), a key protein in blood coagulation. Dysfunction or abnormal concentration of vWF may contribute to gastrointestinal (GIT) bleeding.
Aim: This study aimed to evaluate the relationship between vWF levels/activity and GIT bleeding in adult hemodialysis-dependent ESKD patients.
Patients and methods: A case-control study was conducted at Menoufia University Hospital and Mit Ghamr Nephrology and Urology Hospital over four years (Jan 2021–Dec 2024), including 53 end-stage renal disease (ESRD) patients on maintenance hemodialysis and 48 healthy controls.
Results: Among ESRD patients, 7.5% had clinically evident GIT bleeding (three upper & one lower), and 11.3% had positive occult blood tests (two false positives). vWF antigen (vWF-Ag) levels correlated positively with INR (r=0.349, p=0.01) and serum creatinine, and negatively with GFR. vWF ristocetin cofactor activity (vWF:RCo) also correlated positively with INR. Univariate analysis linked lower albumin, higher vWF-Ag, and higher vWF:RCo to increased GIT bleeding risk. In multivariate analysis, vWF:RCo was an independent predictor. Diagnostic performance showed vWF-Ag had 100% sensitivity, 79.3% specificity, PPV of 40% and AUC of 0.948. vWF:RCo had 100% sensitivity, 77.3% specificity, PPV of 28.6% and AUC of 0.841.
Conclusion: vWF dysfunction contributed to GIT bleeding risk in hemodialysis-treated ESRD patients. Both vWF-Ag and vWF:RCo were associated with bleeding, but vWF:RCo independently predicts risk, suggesting its potential as a biomarker for identifying high-risk patients.
(2025). Association of Von Willebrand Factor Level and Activity with GIT Bleeding in Adult Hemodialysis-Dependent ESRD Patients. The Egyptian Journal of Hospital Medicine, 100(1), 4034-4042. doi: 10.21608/ejhm.2025.413798.1819
MLA
. "Association of Von Willebrand Factor Level and Activity with GIT Bleeding in Adult Hemodialysis-Dependent ESRD Patients", The Egyptian Journal of Hospital Medicine, 100, 1, 2025, 4034-4042. doi: 10.21608/ejhm.2025.413798.1819
HARVARD
(2025). 'Association of Von Willebrand Factor Level and Activity with GIT Bleeding in Adult Hemodialysis-Dependent ESRD Patients', The Egyptian Journal of Hospital Medicine, 100(1), pp. 4034-4042. doi: 10.21608/ejhm.2025.413798.1819
VANCOUVER
Association of Von Willebrand Factor Level and Activity with GIT Bleeding in Adult Hemodialysis-Dependent ESRD Patients. The Egyptian Journal of Hospital Medicine, 2025; 100(1): 4034-4042. doi: 10.21608/ejhm.2025.413798.1819
)
View on SCiNiTO